| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 04/07/2004 | CN1487927A Diaminothiazoles |
| 04/07/2004 | CN1486983A Solidifiable composition containing thiazole functional group |
| 04/07/2004 | CN1144799C N-(iminomethyl) amine derivatives, their preparation, their use as medicines and medical compositions containing the same |
| 04/07/2004 | CN1144797C Polycyclic thiazolidin-2-ylidene amines, producing process thereof and use as medicine |
| 04/07/2004 | CN1144795C Isothiazole formamide |
| 04/07/2004 | CN1144791C Triazole compounds and its application as dopamine-D3-ligands |
| 04/07/2004 | CN1144786C Substituted 3-cyanoquinolines as protein tyrosine kinases inhibitors |
| 04/06/2004 | US6716998 Such as (2r)-3,4-dihydro-2h-chromen-2-yl-methyl-4-methyl-benzenesulfonate; metathesis ring closing polymerization |
| 04/06/2004 | US6716881 Carbanilides used as pesticides |
| 04/06/2004 | US6716871 Cyclic AMP-specific phosphodie sterase inhibitors |
| 04/06/2004 | US6716866 Aryl-benzimidazole compounds having antiinfective activity |
| 04/06/2004 | US6716862 5-(Substituted)-5-(substitutedsulfonyl or sulfanyl) thiazolidine-2,4-diones useful for inhibition of farnesyl-protein transferase |
| 04/06/2004 | US6716861 Heterocyclic 1,2,4-oxadiazole or oxazole ring containing propanohydroxamic acids useful as antiscarring agent |
| 04/06/2004 | US6716851 Substituted 2-aryl-4-arylaminopyrimidines and analogs as activators or caspases and inducers of apoptosis and the use thereof |
| 04/06/2004 | US6716850 Non-nucleoside reverse transcriptase inhibitors |
| 04/06/2004 | US6716842 Non-insulin dependent diabetes mellitus, obesity, hyperglycemia, hyperlipidemia, hypercholesteremia, atherosclerosis, hypertriglyceridemia, hyperinsulinemia in a mammal |
| 04/06/2004 | US6716838 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 04/06/2004 | US6716837 Heterocyclic compounds for the treatment of migraine |
| 04/06/2004 | US6716605 Indole derivatives having an antiviral activity |
| 04/01/2004 | WO2004027378A2 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | WO2004026866A1 N-aroyl cyclic amines as orexin receptor antagonists |
| 04/01/2004 | WO2004026865A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026864A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | WO2004026863A1 Novel oxazole and thiazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026859A1 Novel imidazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026858A1 Substituted heterocyclylpyrimidines |
| 04/01/2004 | WO2004026851A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors |
| 04/01/2004 | WO2004026849A1 Process for preparing substituted phenoxy-acetic acids from phenols |
| 04/01/2004 | WO2004026844A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | WO2004026828A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | WO2004026822A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | WO2004026307A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | WO2004026305A1 Diaryl ethers as opioid receptor antagonist |
| 04/01/2004 | WO2004026254A2 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | WO2004026248A2 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 04/01/2004 | WO2004026226A2 Compounds, compositions and methods |
| 04/01/2004 | WO2003099284B1 Amino-pyridine, -pyridine and pyridazine derivatives for use as vanilloid receptor ligands for the treatment of pain |
| 04/01/2004 | WO2003099281A3 Administration of a partial fatty acid inhibitor such as ranolazine for the treatment of diabetes |
| 04/01/2004 | WO2002102314A3 Purine inhibitors of phosphodiesterase (pde) 7 |
| 04/01/2004 | US20040063955 Antichoelsterol agents; cardiovascular disorders; antihistamines; multiple sclerosis; antihistamines |
| 04/01/2004 | US20040063954 Antibacterial cyano-(substituted)-methylenepiperidinophenyl oxazolidinones targeting multiple ribonucleoprotein sites |
| 04/01/2004 | US20040063946 Jnk inhibitor |
| 04/01/2004 | US20040063940 3,3-Biarylpiperidine and 2,2-biarylmorpholine derivatives |
| 04/01/2004 | US20040063937 Microbiocidal n-phenyl-n-[4-(4-pyridyl-2-pyrimidin-2-yl]-amine derivatives |
| 04/01/2004 | US20040063935 Aliphatic nitrogenous five-membered ring compounds |
| 04/01/2004 | US20040063783 Used to treat pathologies characterized by an oxidative stress condition and a lack of availability of endothelial nitrogen monoxide, such as ischemia, restenosis, erectile dysfunction, hypoxia, transplant rejection and diabetes |
| 04/01/2004 | US20040063775 Five-membered heterocyclic alkanoic acid derivative |
| 04/01/2004 | US20040063771 Bis-sulfonamide hydroxyethyl-amino retroviral protease inhibitors |
| 04/01/2004 | US20040063767 Reacting an alpha-substituted ketone with a cyclictetramine to form quaternaryammonium salt, reacting the salt with an acid to form alpha-amino ketone, reacting ketone with alpha-substitued acyl derivative in presence of a base |
| 04/01/2004 | US20040063764 Halogen compounds having thrombopoietin receptor agonism |
| 04/01/2004 | US20040063746 For treatment of HIV |
| 04/01/2004 | US20040063745 2-amino-4-(pyridin-2-yl)-thiazole derivatives as transforming growth factor beta (tgf-beta) inhibitors |
| 04/01/2004 | US20040063737 CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agents |
| 04/01/2004 | US20040063733 Quinazoline derivatives |
| 04/01/2004 | US20040063720 Tyrosine kinase inhibitors |
| 04/01/2004 | US20040063717 Employing fatty acid oxidation inhibitor; lowering HbA1c, glucose, total cholesterol and/or triglyceride plasma levels; increasing high density lipoprotein concentration; minimizing side effects; ranolazine |
| 04/01/2004 | US20040063709 Acute and chronic inflammatory disorders; cancer |
| 04/01/2004 | US20040063705 Substituted pyrimidinyl derivatives and methods of use |
| 04/01/2004 | US20040063696 Antiinflammatories targeting cartilage tissue; limiting side effects; arthritis, arthrosis |
| 04/01/2004 | US20040063691 Preparation and use of imidazole derivatives for treatment of obesity |
| 04/01/2004 | US20040063682 Hydrolysis of tert-butyl ester with mineral acid |
| 04/01/2004 | US20040063677 Omega monounsaturated fatty acid derivativatized biologically active materials; drug delivery; drug resistance; bioavail-ability |
| 04/01/2004 | US20040063671 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 04/01/2004 | US20040063665 Anticancer agents; high degree of discrimination toward malignant cells; reducing side effects; nontoxic; such as 3-chloro-2-(3,4-dihydroxyphenyl)-7,8-dihydroxy-4H-chromen-4-one |
| 04/01/2004 | US20040063643 Bombesin antagonists |
| 04/01/2004 | US20040063584 Benzazolonylcarbonylcyclohexenones and their use ss herbicides |
| 04/01/2004 | US20040063021 Diazonium salt and thermal recording material using the same |
| 04/01/2004 | US20040062713 Dye; photosensitive stimulant; using eye |
| 04/01/2004 | CA2768674A1 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 04/01/2004 | CA2695720A1 Method of producing epothilone b by culturing sorangium cellulosum in a medium comprising propionic acid |
| 04/01/2004 | CA2695671A1 Methods for the preparation, isolation and purification of epothilone b, and x-ray crystal structures of epothilone b |
| 04/01/2004 | CA2499964A1 Methods and compositions of novel triazine compounds |
| 04/01/2004 | CA2499701A1 Pyrrole derivatives as antimycobacterial compounds |
| 04/01/2004 | CA2499332A1 Novel isothiazole and isoxazole compounds as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2499326A1 Heterocyclic substituted piperazines for the treatment of schizophrenia |
| 04/01/2004 | CA2499150A1 Octahydro-2-h-naphtho[1,2-f] indole-4-carboxamide derivatives as selective glucocorticoid receptor modulators |
| 04/01/2004 | CA2498149A1 3-(3,5-disubstituted-4-hydroxyphenyl)propionamide derivatives as cathepsin b inhibitors |
| 04/01/2004 | CA2497971A1 Triazole derivatives as transforming growth factor (tgf) inhibitors |
| 04/01/2004 | CA2497560A1 Luminescence-based methods and probes for measuring cytochrome p450 activity |
| 04/01/2004 | CA2496306A1 Substituted heterocyclylpyrimidines |
| 03/31/2004 | EP1403704A1 Dye-forming coupler and silver halide color photographic light-sensitive material |
| 03/31/2004 | EP1403255A1 Rho KINASE INHIBITORS |
| 03/31/2004 | EP1403253A1 Novel heterocyclic compound and medicinal use thereof |
| 03/31/2004 | EP1402900A1 Medicinal compositions |
| 03/31/2004 | EP1401825A2 Thiophene derivatives as antiviral agents for flavivirus infection |
| 03/31/2004 | EP1401820A1 5-ht receptor ligands and uses thereof |
| 03/31/2004 | EP1401819A1 5-ht receptor ligands and uses thereof |
| 03/31/2004 | EP1401817A1 Isoquinoline compounds having antiinfective activity |
| 03/31/2004 | EP1401451A2 Quinazoline derivatives which promote the release of parathyroid hormone |
| 03/31/2004 | EP1401443A1 Novel anti-infectives |
| 03/31/2004 | EP1401439A1 Use of bicyclo compounds for treating alzheimer's disease |
| 03/31/2004 | EP1401436A1 Thiazolyl amides and their use as antiviral drugs |
| 03/31/2004 | EP1401435A1 Topical application of thiazolyl amides |
| 03/31/2004 | EP1401434A1 Modulators of peroxisome proliferator activated receptors (ppar) |
| 03/31/2004 | EP1401351A2 Method for treating glaucoma vi |
| 03/31/2004 | EP1370258A4 Peptide deformylase inhibitors |
| 03/31/2004 | EP1233944B1 Coupling condensation synthesis of heterocycles |
| 03/31/2004 | EP1181294B1 Novel derivatives and analogues of galanthamin |
| 03/31/2004 | EP1121349B1 Substituted thiadiazolsulfonamides used as interleukin-1-beta inhibitors |
| 03/31/2004 | CN1486312A Pyrazole compounds useful as protein kinase inhibitors |